Literature DB >> 30146030

Mold Infections in Solid Organ Transplant Recipients.

Tracy L Lemonovich1.   

Abstract

Mold infections carry a substantial clinical and economic burden in solid organ transplant (SOT) recipients with a high overall mortality of near 30%. The most important pathogens include Aspergillus, the Zygomycetes, Fusarium, Scedosporium/Pseudallescheria, and the dematiaceous (dark) molds. Risk factors for the infections vary by transplant type but include degree of immune suppression and loss of skin or mucosal integrity. Correct diagnosis usually requires histopathology and/or culture. Management often requires a multidisciplinary team approach with combined antifungal and surgical therapies. This article reviews the epidemiology, risk factors, microbiology, diagnostic, and treatment approach to mold infections in SOT recipients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antifungal; Aspergillosis; Fusariosis; Invasive fungal infections; Mucormycosis; Transplant

Mesh:

Substances:

Year:  2018        PMID: 30146030     DOI: 10.1016/j.idc.2018.04.006

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  3 in total

1.  Mucormycosis: Literature review and retrospective report of 15 cases from Portugal.

Authors:  Beatriz Prista Leão; Isabel Abreu; Ana Cláudia Carvalho; António Sarmento; Lurdes Santos
Journal:  Curr Med Mycol       Date:  2020-12

2.  (1→3)-β-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people.

Authors:  Sandra K White; Robert L Schmidt; Brandon S Walker; Kimberly E Hanson
Journal:  Cochrane Database Syst Rev       Date:  2020-07-21

3.  12/15-Lipoxygenase Deficiency Impairs Neutrophil Granulopoiesis and Lung Proinflammatory Responses to Aspergillus fumigatus.

Authors:  Joseph J Mackel; Jaleesa M Garth; Jonathan P Blackburn; MaryJane Jones; Chad Steele
Journal:  J Immunol       Date:  2020-02-26       Impact factor: 5.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.